Vendor, Sharon, MA
Boston Cell Standards Inc.
UEI HA17F32KXEV8, CAGE 48QH5
1 award and $1,995,119 obligated between September 9, 2024 and September 11, 2026, 100% under full and open competition, against 11.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $1,995,119 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Boston Cell Standards Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Boston Cell Standards Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $1,995,119
- Soonest
- January 15, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,453,292 |
| Westat, Inc.Rockville, MD | $762,955,645 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00087Definitive Contract, September 9, 2024, Full and Open Competition After Exclusion of Sources, 11 offers | NIH NCINational Institutes of Health | FY24 SBIR Phase II RD Contract - Topic 442 Boston Cell Standards, INC.NAICS 541715, PSC AN12 | $1,995,119 |
- Places of performance
- Massachusetts
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 3 across 1 awards